Mechanisms of chemical injury of thyroid gland

C C Capen1

  • 1Department of Veterinary Pathobiology, Ohio State University, Columbus 43210.

Progress in Clinical and Biological Research
|January 1, 1994
PubMed

Insights

Many chemicals and physiological changes can disrupt thyroid hormone production and metabolism, leading to increased thyroid tumors in rodents. Chronic overstimulation by thyroid-stimulating hormone (TSH) is a key factor in this process.

Area of Science:

  • Endocrinology
  • Toxicology
  • Oncology

Background:

  • Goitrogenic xenobiotics and physiological perturbations can disrupt thyroid hormone homeostasis.
  • These disruptions can lead to increased incidence of thyroid tumors in rodent models.
  • Understanding these mechanisms is crucial for assessing chemical safety and thyroid cancer risk.

Purpose of the Study:

  • To review the mechanisms by which xenobiotics and physiological factors disrupt thyroid hormone economy.
  • To elucidate the role of chronic thyroid-stimulating hormone (TSH) hypersecretion in rodent thyroid oncogenesis.
  • To categorize goitrogenic agents based on their mode of action on the thyroid gland.

Main Methods:

  • Literature review of studies on goitrogenic xenobiotics and thyroid tumorigenesis in rodents.
  • Categorization of goitrogens based on their effects on thyroid hormone biosynthesis, secretion, metabolism, and TSH regulation.
  • Analysis of the common pathway involving chronic TSH stimulation in thyroid tumor development.

Main Results:

  • Goitrogens disrupt thyroid hormone economy via direct effects on hormone synthesis/secretion or by increasing peripheral metabolism.
  • Inhibition of 5'monodeiodinase lowers T3, leading to compensatory TSH increase.
  • Chronic TSH hypersecretion is a consistent finding and a secondary mechanism driving rodent thyroid tumor development.

Conclusions:

  • Both xenobiotic chemicals and physiological perturbations can lead to thyroid tumors in rodents.
  • Chronic TSH stimulation is a critical factor in the secondary mechanism of rodent thyroid oncogenesis.
  • Identifying and understanding goitrogenic mechanisms is essential for risk assessment.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...